Both in Pharmaceuticals
Altimmune vs Indaptus Therapeutics
Over the past year ALT returned −47.6% and INDP returned +4.5%; their daily moves had a correlation of 0.05.
ALT −47.6% INDP +4.5%Growth of $1, one year, split-adjusted
| Metric | ALT | INDP |
|---|---|---|
| Price | $2.08 | $3.26 |
| Market cap | $403.6M | $434.4M |
| Today | +2.72% | −6.86% |
| 1 month | −22.3% | +29.9% |
| 6 months | −32.2% | +56.0% |
| Year to date | −42.5% | +12.0% |
| 1 year | −48.8% | +1.2% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 13,020.1× | — |
| Net cash | $291.5M | $11.6M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 193.3% |
| Short % of float | 22.2% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).